DK1289945T3 - Anilindisulfidderivater til behandling af allergiske sygdomme - Google Patents

Anilindisulfidderivater til behandling af allergiske sygdomme

Info

Publication number
DK1289945T3
DK1289945T3 DK01930719T DK01930719T DK1289945T3 DK 1289945 T3 DK1289945 T3 DK 1289945T3 DK 01930719 T DK01930719 T DK 01930719T DK 01930719 T DK01930719 T DK 01930719T DK 1289945 T3 DK1289945 T3 DK 1289945T3
Authority
DK
Denmark
Prior art keywords
treatment
allergic diseases
disulfide derivatives
aniline
aniline disulfide
Prior art date
Application number
DK01930719T
Other languages
Danish (da)
English (en)
Inventor
Mark R Hellberg
Zixia Feng
Steven T Miller
Original Assignee
Alcon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Inc filed Critical Alcon Inc
Application granted granted Critical
Publication of DK1289945T3 publication Critical patent/DK1289945T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
    • C07C323/43—Y being a hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
    • C07C323/40—Y being a hydrogen or a carbon atom
    • C07C323/41—Y being a hydrogen or an acyclic carbon atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK01930719T 2000-05-19 2001-04-25 Anilindisulfidderivater til behandling af allergiske sygdomme DK1289945T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20574600P 2000-05-19 2000-05-19
PCT/US2001/013242 WO2001090059A1 (en) 2000-05-19 2001-04-25 Aniline disulfide derivatives for treating allergic diseases

Publications (1)

Publication Number Publication Date
DK1289945T3 true DK1289945T3 (da) 2004-11-01

Family

ID=22763478

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01930719T DK1289945T3 (da) 2000-05-19 2001-04-25 Anilindisulfidderivater til behandling af allergiske sygdomme

Country Status (19)

Country Link
US (2) US6372802B2 (enExample)
EP (1) EP1289945B1 (enExample)
JP (1) JP2003534317A (enExample)
KR (1) KR20020093982A (enExample)
CN (1) CN1173697C (enExample)
AR (1) AR028565A1 (enExample)
AT (1) ATE272619T1 (enExample)
AU (2) AU5722701A (enExample)
BR (1) BR0110845A (enExample)
CA (1) CA2408145A1 (enExample)
DE (1) DE60104690T2 (enExample)
DK (1) DK1289945T3 (enExample)
ES (1) ES2222370T3 (enExample)
MX (1) MXPA02011480A (enExample)
PL (1) PL365459A1 (enExample)
PT (1) PT1289945E (enExample)
TR (1) TR200402299T4 (enExample)
WO (1) WO2001090059A1 (enExample)
ZA (1) ZA200208839B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001045668A2 (en) * 1999-12-20 2001-06-28 Schering Corporation Stable extended release oral dosage composition comprising pseudoephedrine and desloratadine
AU2276801A (en) 1999-12-20 2001-07-03 Schering Corporation Extended release oral dosage composition
UA82323C2 (uk) * 2002-08-09 2008-04-10 Меда Фарма Гмбх & Ко. Кг Нова комбінація глюкокортикоїду та pde-інгібітору для лікування респіраторних захворювань, алергічних захворювань, астми та хронічних обструктивних легеневих захворювань
CA2567156A1 (en) * 2004-05-17 2006-07-20 Cambrios Technology Corp. Biofabrication of transistors including field effect transistors
WO2006004757A2 (en) * 2004-06-28 2006-01-12 Alcon, Inc. Topical formulations for treating allergic diseases
US20130304180A1 (en) * 2012-05-09 2013-11-14 Michael L. Green Catheter having dual balloon hydraulic actuator
US11058444B2 (en) 2017-12-11 2021-07-13 Covidien Lp Electrically enhanced retrieval of material from vessel lumens

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1232787A (enExample) 1967-08-08 1971-05-19
US3663616A (en) 1969-10-13 1972-05-16 Sherwin Williams Co Bis(2-carbamylphenyl)disulfides
EP0006227B1 (en) 1978-06-16 1984-12-27 Kyowa Hakko Kogyo Co., Ltd Antithrombotic pharmaceutical preparation containing 2,2'-dithiobis benzamide derivatives and new 2,2'-dithiobis benzamide derivatives
JPS59205356A (ja) * 1983-05-10 1984-11-20 Teikoku Hormone Mfg Co Ltd ジスルフアニルベンゼン酢酸誘導体
US4923892A (en) 1985-08-17 1990-05-08 Burroughs Wellcome Co. Tricyclic aromatic compounds
GB8520662D0 (en) 1985-08-17 1985-09-25 Wellcome Found Tricyclic aromatic compounds
JPS6310784A (ja) 1986-03-03 1988-01-18 Kyowa Hakko Kogyo Co Ltd 抗アレルギー剤
GB9020933D0 (en) 1990-09-26 1990-11-07 Ici Plc Compound,preparation and use
US5859017A (en) 1994-04-01 1999-01-12 Cell Therapeutics, Inc. Method for inhibiting mast cell and basophil activation
US5463122A (en) 1994-08-05 1995-10-31 Warner-Lambert Company Arylthio compounds
US5734081A (en) 1994-08-05 1998-03-31 Warner-Lambert Company Arylthio compounds
US6001555A (en) 1994-09-23 1999-12-14 The United States Of America As Represented By The Department Of Health And Human Services Method for identifying and using compounds that inactivate HIV-1 and other retroviruses by attacking highly conserved zinc fingers in the viral nucleocapsid protein
JPH08253454A (ja) * 1994-12-26 1996-10-01 Nisshin Flour Milling Co Ltd ジフェニルジスルフィド化合物
JPH095926A (ja) 1995-04-18 1997-01-10 Fuji Photo Film Co Ltd 熱現像感光材料
US5641805A (en) 1995-06-06 1997-06-24 Alcon Laboratories, Inc. Topical ophthalmic formulations for treating allergic eye diseases
US6225327B1 (en) 1996-04-18 2001-05-01 Alcon Laboratories, Inc. Compounds which inhibit human conjunctival mast cell degranulation for treating ocular allergic-type complications
JP2894445B2 (ja) 1997-02-12 1999-05-24 日本たばこ産業株式会社 Ｃｅｔｐ活性阻害剤として有効な化合物
JP3940201B2 (ja) 1997-05-20 2007-07-04 大塚製薬株式会社 ３，３’−ジチオジベンゾヒドロキサム酸
JP3702382B2 (ja) * 1997-10-22 2005-10-05 参天製薬株式会社 ＮＦ−κＢ活性化阻害剤
JP2003534318A (ja) * 2000-05-19 2003-11-18 アルコン，インコーポレイテッド アレルギー性疾患を処置するために有用なジスルフィド誘導体
DK1284722T3 (da) * 2000-05-19 2005-09-19 Alcon Inc Sammensætninger indeholdende et benzamiddisulfidderivat til behandling af allergiske sygdomme
JP2002193796A (ja) * 2000-12-27 2002-07-10 Ajinomoto Co Inc 炎症因子活性化抑制剤、その用途及びそのために使用可能な新規ポリスルフィド誘導体

Also Published As

Publication number Publication date
US6452052B1 (en) 2002-09-17
BR0110845A (pt) 2003-02-11
JP2003534317A (ja) 2003-11-18
US20020013311A1 (en) 2002-01-31
AU2001257227B2 (en) 2005-04-07
DE60104690T2 (de) 2005-01-13
CN1429208A (zh) 2003-07-09
EP1289945B1 (en) 2004-08-04
CN1173697C (zh) 2004-11-03
TR200402299T4 (tr) 2004-12-21
KR20020093982A (ko) 2002-12-16
CA2408145A1 (en) 2001-11-29
ZA200208839B (en) 2004-02-03
EP1289945A1 (en) 2003-03-12
HK1050677A1 (en) 2003-07-04
US6372802B2 (en) 2002-04-16
ES2222370T3 (es) 2005-02-01
ATE272619T1 (de) 2004-08-15
PL365459A1 (en) 2005-01-10
DE60104690D1 (de) 2004-09-09
AR028565A1 (es) 2003-05-14
PT1289945E (pt) 2004-10-29
MXPA02011480A (es) 2003-06-06
US20020115658A1 (en) 2002-08-22
AU5722701A (en) 2001-12-03
WO2001090059A1 (en) 2001-11-29

Similar Documents

Publication Publication Date Title
DK1343773T3 (da) Thiazolderivater til behandling af PPAR-beslægtede forstyrrelser
DK1944322T3 (da) Behandling af TNFalfa-relaterede sygdomme
DK1438306T3 (da) Derivater af UK-2A
NO20031442L (no) Morfolin-acetamidderivater for behandling av inflammatoriske sykdommer
DK1425001T3 (da) Phenethanolaminderivater til behandling af respiratoriske sygdomme
DK1474416T3 (da) Dihydrobenzodiazepin-2-on-derivater til behandlingen af neurologiske lidelser
DK1562932T3 (da) 4 tetrazolyl-4-phenylpiperidinderivater til behandling af smerter
DK1448205T3 (da) Kombinationer til behandling af immunoinflammatoriske sygdomme
DK1575597T3 (da) Anvendelse af rimexolon til behandling af öjentörhed
DE60223278D1 (de) Nicotin- oder isonicotin benzothiazole derivaten
DK1411926T3 (da) Integrininhibitorer til behandling af öjensygdomme
DK1289945T3 (da) Anilindisulfidderivater til behandling af allergiske sygdomme
DK1687297T3 (da) Triazindimerer til behandling af autoimmunsygdomme
DK1282599T3 (da) Disulfidderivater, der er egnede til behandling af allergiske sygdomme
DK1309322T3 (da) Anvendelse af 3-benzoylphenyleddikesyrederivater til behandling af retinale lidelser
DE50113918D1 (de) Quengel-Orthese
ATE330603T1 (de) Benzothiazolderivaten
DK1468996T3 (da) Indolderivater til behandling af CNS-sygdomme
PT1268482E (pt) Piranoindois para o tratamento de glaucoma
DK1200447T3 (da) Oxazinocarbazoler til behandling af CNS-sygdomme
PT1392670E (pt) Derivados substituidos de c-furan-2-il-metilamina e c-tiofen-2-il-metilamina
DK1341766T3 (da) Imidazolonderivater til behandling af virussygdomme
DK1284722T3 (da) Sammensætninger indeholdende et benzamiddisulfidderivat til behandling af allergiske sygdomme
NO20033290D0 (no) Pyrrolderivater for behandling av cytokinformidlede sykdommer
FR2843304B1 (fr) Extraits de sangsues pour stents